We are Sorry, This Page doesn't Exist
Tonix Pharmaceuticals provides retrospective analysis of two studies at MHSRS
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA lifts partial hold on Pieris Pharmaceuticals" phase 1 studies of PRS-343
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Verrica Pharmaceuticals presents data from clinical studies of VP-102
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Kitov Pharmaceuticals to present Phase 1 data on CM-24
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Citius Pharmaceuticals to present data on ARDS candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers to present data from over 50 company-sponsored studies at ASCO20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
InDex Pharmaceuticals Holding AB (publ) Interim Report January - March 2020
STOCKHOLM, May 7, 2020 /PRNewswire/ -- FDA and EMA endorse the advancement of cobitolimod into phase III studies "The positive responses from the regulators is an important external validation of our study results and cobitolimod's po.....»»
Regeneron earnings beat expectations, plans to begin human studies of COVID-19 treatment in June
Regeneron Pharmaceuticals Inc. reported Tuesday profit and revenue that rose above expectations, and said it plans to begin human studies of its REGN-COV2 antibody "cocktail" treatment for the COVID-19 virus .....»»
Paratek Pharmaceuticals pauses recruitment in ongoing clincial studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vaccinex expects interim analysis of Window-of Opportunity studies in May/June
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bitcoin, Ethereum & Litecoin - American Wrap: 2/25/2020
Bitcoin Price Analysis: BTC/USD continues to make lower high and lower low waves Bitcoin is having a tough time at present as sentiment fails to turn once again on Tuesday. read more.....»»
MannKind to present results from multiple studies of Afrezza, BluHale system
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hepion Pharmaceuticals announces results from CRV431 in vitro studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aveo Pharmaceuticals, Biodesix present results from ficlatuzumab trial at ASCO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sell your extended-share-price stocks of firms with falling growth
Overview In this article, we provide a broad market index review with a 2020 outlook, present an analysis of the S&P 500 Index, highlight the... The post Sell your extended-share-price stocks of firms with falling growth appeared first on ValueWalk......»»
Citius Pharmaceuticals reports positive Phase 3 Mino-Lok futility analysis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Corbus Pharmaceuticals announces data from lenabasum OLE studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»
Rhythm Pharmaceuticals to present data from two Phase 3 trials of setmelanotide
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Paratek Pharmaceuticals announces results of tetracycline omadacycline studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»